{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:44:41Z","timestamp":1790264681650,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00112","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T07:32:23Z","timestamp":1459323143000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Marrow-Infiltrating Lymphocytes \u2013 Role in Biology and Cancer Therapy"],"prefix":"10.3389","volume":"7","author":[{"given":"Ivan","family":"Borrello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"issue":"4","key":"B1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"B2","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1172\/JCI80010","article-title":"CAR therapy: the CD19 paradigm","volume":"125","author":"Sadelain","year":"2015","journal-title":"J Clin Invest"},{"issue":"9","key":"B3","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/eji.201545552","article-title":"Adoptive T-cell therapy for cancer: the era of engineered T cells","volume":"45","author":"Bonini","year":"2015","journal-title":"Eur J Immunol"},{"issue":"5594","key":"B4","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"issue":"5","key":"B5","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1158\/0008-5472.CAN-04-3337","article-title":"Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors","volume":"65","author":"Noonan","year":"2005","journal-title":"Cancer Res"},{"issue":"12","key":"B6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.molmed.2003.10.001","article-title":"T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity","volume":"9","author":"Schirrmacher","year":"2003","journal-title":"Trends Mol Med"},{"issue":"9","key":"B7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nm914","article-title":"Bone marrow as a priming site for T-cell responses to blood-borne antigen","volume":"9","author":"Feuerer","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"B8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/86523","article-title":"Therapy of human tumors in NOD\/SCID mice with patient-derived reactivated memory T cells from bone marrow","volume":"7","author":"Feuerer","year":"2001","journal-title":"Nat Med"},{"issue":"7","key":"B9","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/1521-4141(200207)32:71873::AID-IMMU18733.0.CO;2-P","article-title":"Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery","volume":"32","author":"Di Rosa","year":"2002","journal-title":"Eur J Immunol"},{"issue":"11","key":"B10","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.4049\/jimmunol.180.11.7230","article-title":"Kinetics of in vivo proliferation and death of memory and naive CD8 T cells: parameter estimation based on 5-bromo-2\u2019-deoxyuridine incorporation in spleen, lymph nodes, and bone marrow","volume":"180","author":"Parretta","year":"2008","journal-title":"J Immunol"},{"issue":"7","key":"B11","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.4049\/jimmunol.155.7.3338","article-title":"Extrathymic maturation of alpha beta T cells from hemopoietic stem cells","volume":"155","author":"Dejbakhsh-Jones","year":"1995","journal-title":"J Immunol"},{"issue":"1","key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/cmi.2011.47","article-title":"Bone marrow and the control of immunity","volume":"9","author":"Zhao","year":"2012","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"B13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.immuni.2005.01.008","article-title":"Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells","volume":"22","author":"Mazo","year":"2005","journal-title":"Immunity"},{"issue":"2","key":"B14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4049\/jimmunol.165.2.716","article-title":"Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells","volume":"165","author":"Jourdan","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"B15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4049\/jimmunol.1400488","article-title":"Cutting edge: CXCR4 is critical for CD8+ memory T cell homeostatic self-renewal but not rechallenge self-renewal","volume":"193","author":"Chaix","year":"2014","journal-title":"J Immunol"},{"issue":"1","key":"B16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"},{"issue":"22","key":"B17","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1158\/0008-5472.CAN-04-1987","article-title":"Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12\/CXCR4 signals","volume":"64","author":"Zou","year":"2004","journal-title":"Cancer Res"},{"issue":"18","key":"B18","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1182\/blood-2010-05-283895","article-title":"A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma","volume":"116","author":"Noonan","year":"2010","journal-title":"Blood"},{"issue":"26","key":"B19","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1182\/blood-2009-10-246660","article-title":"Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma","volume":"115","author":"Prabhala","year":"2010","journal-title":"Blood"},{"issue":"10","key":"B20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/ni1249","article-title":"Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells","volume":"6","author":"Cavanagh","year":"2005","journal-title":"Nat Immunol"},{"issue":"5","key":"B21","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.V90.5.2103","article-title":"Bone marrow contains virus-specific cytotoxic T lymphocytes","volume":"90","author":"Slifka","year":"1997","journal-title":"Blood"},{"issue":"8","key":"B22","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1182\/blood-2008-02-138040","article-title":"Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow","volume":"112","author":"Palendira","year":"2008","journal-title":"Blood"},{"issue":"1","key":"B23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/1097-0215(200102)9999:9999::AID-IJC11523.0.CO;2-Q","article-title":"Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients","volume":"92","author":"Feuerer","year":"2001","journal-title":"Int J Cancer"},{"issue":"12","key":"B24","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1158\/0008-5472.CAN-04-0484","article-title":"Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration","volume":"66","author":"Muller-Berghaus","year":"2006","journal-title":"Cancer Res"},{"issue":"21","key":"B25","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.1158\/0008-5472.CAN-05-1098","article-title":"High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients","volume":"65","author":"Schmitz-Winnenthal","year":"2005","journal-title":"Cancer Res"},{"issue":"288","key":"B26","doi-asserted-by":"publisher","first-page":"288ra78","DOI":"10.1126\/scitranslmed.aaa7014","article-title":"Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma","volume":"7","author":"Noonan","year":"2015","journal-title":"Sci Transl Med"},{"issue":"2","key":"B27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/107327480200900205","article-title":"Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation","volume":"9","author":"Luznik","year":"2002","journal-title":"Cancer Control"},{"issue":"6","key":"B28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/MOH.0b013e32833eaf1b","article-title":"High-dose cyclophosphamide for graft-versus-host disease prevention","volume":"17","author":"Luznik","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"5795","key":"B29","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"1","key":"B30","first-page":"264","article-title":"Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma","volume":"9","author":"Zhang","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"4","key":"B31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jamaoncol.2015.0830","article-title":"Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib and trastuzumab: a secondary analysis of the NeoALTTO Trial","volume":"1","author":"Salgado","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"B32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Hinrichs","year":"2014","journal-title":"Immunol Rev"},{"issue":"6","key":"B33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00262-008-0605-3","article-title":"Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study","volume":"58","author":"Schuetz","year":"2009","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"B34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00262-013-1414-x","article-title":"Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial","volume":"62","author":"Domschke","year":"2013","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"B35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"issue":"16","key":"B36","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"issue":"224","key":"B37","doi-asserted-by":"publisher","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci Transl Med"},{"issue":"26","key":"B38","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1182\/blood-2014-12-580068","article-title":"CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"issue":"7","key":"B39","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-06-438002","article-title":"Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia","volume":"121","author":"Haso","year":"2013","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T11:43:09Z","timestamp":1692272589000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00112\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00112","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}